Abstract:In this work, our primary objective was to examine the interrelationship among the serum level of chemokine (C-C motif) ligand 2 (CCL2) and plaque characteristics in coronary culprit lesions. The clinical data of 116 coronary heart disease patients who were hospitalized in the Department of Cardiology of Henan Province People's Hospital from February 2015 to June 2017 were retrospectively analyzed. The study population was subdivided according to the concentration of CCL2 into low CCL2 group and high CCL2 group. The levels of blood lipid, creatinine, and uric acid were measured, and patients underwent coronary angiography. The characteristics of the culprit lesions were detected by intravascular ultrasound, and the correlation between the serum markers and the characteristics of coronary artery plaque was analyzed. Moreover, the coronary artery disease dataset from the Gene Expression Omnibus database was downloaded and the genes regulated were analyzed by CCL2 using gene set enrichment analysis (GSEA). Patients with high CCL2 group had higher LDL-C level and L/H ratio, and lower HDL-C level than the low CCL2 group. Compared with low-level CCL2 group, coronary plaque in the high CCL2 group had higher eccentric plaque and plaque rupture, and thin cap fibroatheromas, fibrofatty and necrotic core and lower fibrous tissue. CCL2 was positively correlated with the percentage of fibrofatty and necrotic core, and negatively correlated with the percentage of fibrous tissue. Furthermore, GSEA analysis showed that samples with high CCL2 expression were enriched for genes involved in different pathways, such as cell adhesion molecules and Nod-like receptor signaling pathway. The CCL2 level was correlated with vulnerable plaques of coronary artery and had certain value in detecting vulnerable plaques. These results indicated that CCL2 could be regarded as a clinical prognostic biomarker for coronary artery disease. Impact statement Vulnerable plaques are plaques which are susceptible to rupture or thrombosis and trigger a series of adverse events such as coronary disorders. CCL2 is a soluble basic protein belonging to the CC subfamily. Previous studies have been investigated on the correlation between inflammatory factors and clinical events, but there are few studies on the correlation between CCL2 and plaque characteristics. Our study found that the high expression of CCL2 is involved in multiple processes in the genesis and progression of coronary artery disease, and would be a potential clinical prognostic indicator. In addition, high expression of CCL2 may be related to gene pathways such as Nod-like receptor signaling pathway, suggesting that CCL2 is involved in the inflammatory response and immune process of coronary artery disease.

MCP-1: Function, regulation, and involvement in disease

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

Involvement of Multiple Transcription Factors in Regulation of IL-β-induced MCP-1 Expression in Alveolar Type II Epithelial Cells.

Abstract 226: Elevated Brain MCP-1 Contributes to Neuroinflammation in Hypertension

The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments

Role of MCP-1 as an inflammatory biomarker in nephropathy

Chemokine (C-C Motif) Ligand 2 (CCL2) in Sera of Patients with Type 1 Diabetes and Diabetic Complications.

The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?

MCP-1 and Monocyte Infiltrating Oculopathy

Expression of RNATES,MCP-1 in serum and synovial fluid in patients with rheumatoid arthritis and its clinical significance

Research progress on relationship between monocyte chemoattractant protein-1 and oral diseases

The molecular structure and role of CCL2 (MCP‐1) and C‐C chemokine receptor CCR2 in skeletal biology and diseases

Correlation Between Monocyte Chemoattractant Protein-1/Chemokine (C-C Motif) Ligand 2 and Coronary Plaque Characteristics.

Monocyte Chemotactic Protein-Induced Protein 1 (MCPIP-1): A Key Player of Host Defense and Immune Regulation

Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis

Advances in the research of MCP-1-induced protein-1

The role of CCL8 in immune regulation of diseases

Monocyte Chemotactic Protein-1 (MCP-1) Acts As a Paracrine and Autocrine Factor for Prostate Cancer Growth and Invasion

MCP-1 Expression Associated with Inflammation and Biomaterials

Expression of Monocyte Chemoatractant Protein 1 in Colonic Mucosa of Patients with Ulcerative Colitis.

CCL13 and human diseases